Glover v. United States

Court of Appeals for the Tenth Circuit·Decided June 9, 2000·No. 99-5043·Unpublished

Opinion

F I L E D

United States Court of Appeals Tenth Circuit

UNITED STATES COURT OF APPEALS JUN 9 2000

FOR THE TENTH CIRCUIT

PATRICK FISHER

Clerk

UNITED STATES OF AMERICA,

Plaintiff-Appellee, No. 99-5043 (D.C. No. 97-CV-22-C)

v. (N.D. Okla.)

ROY GLOVER, Defendant-Appellant.

UNITED STATES OF AMERICA,

Plaintiff-Appellee, No. 99-5046

v. (D.C. No. 94-CV-1011-C)

(N.D. Okla.)

MICHAEL ANTHONY YOUNGPETER,

Defendant-Appellant.

UNITED STATES OF AMERICA,

Plaintiff-Appellee, No. 99-5051

v. (D.C. No. 97-CV-515-C)

(N.D. Okla.)

JOHNNY E. GLOVER,

Defendant-Appellant.

UNITED STATES OF AMERICA,

Plaintiff-Appellee,

No. 99-5054

v. (D.C. No. 97-CV-414-C)

(N.D. Okla.)

RANDY GLOVER,

Defendant-Appellant.

ORDER AND JUDGMENT *

Before KELLY , HENRY , and MURPHY , Circuit Judges.

After examining the briefs and appellate record, this panel has determined unanimously that oral argument would not materially assist the determination of these appeals. See Fed. R. App. P. 34(a)(2); 10th Cir. R. 34.1(G). The cases are therefore ordered submitted without oral argument.

These companioned appeals arise out of an underlying drug conspiracy involving a number of defendants, three of whom, Roy Glover, Randy Glover, and

*

This order and judgment is not binding precedent, except under the doctrines of law of the case, res judicata, and collateral estoppel. The court generally disfavors the citation of orders and judgments; nevertheless, an order and judgment may be cited under the terms and conditions of 10th Cir. R. 36.3.

Johnny Glover, are now before this court seeking certificates of appealability (COA) in order to appeal the district court’s dismissal of their motions to vacate, set aside, or correct an illegal sentence under 28 U.S.C. § 2255. Michael Youngpeter, the fourth defendant before this court, requests a certificate of probable cause (CPC), which we construe as a request for COA. See Fed. R. App. P. 22(b)(2). For the reasons that follow, we conclude defendants each have failed to make a “substantial showing of the denial of a constitutional right” and we deny their requests for COA. 28 U.S.C. § 2253(c)(2).

I. Background

The underlying facts are discussed only as relevant; they have been set forth in prior decisions of this court. Facts that pertain only to a particular defendant are discussed in the context of that defendant’s § 2255 motion only. In brief, defendants–some of whom are related–were convicted of participating in a drug ring that manufactured and sold methamphetamine. At trial and during sentencing (after conviction by jury or guilty plea), the government maintained that because it had not collected any samples from the crime scene, it did not perform any chemical analyses of the methamphetamine. Nevertheless, the district court sentenced all the defendants under the sentencing guidelines then in effect for d-methamphetamine, rather than the sentencing guidelines then in effect

for l-methamphetamine. 1 Subsequently, we remanded the § 2255 motions of two

co-defendants, Robert Glover and David Wann (neither of whom are presently before us), and ordered the district court to hold an evidentiary hearing to determine whether the methamphetamine isomer was d- or l-. See United States v. Robert Glover , 97 F.3d 1345 (10th Cir. 1996). In that context, this court explained that it was the government’s post-conviction “burden of proof and production to show by a preponderance of the evidence the type of methamphetamine involved in [defendants’] offenses.” Id. at 1347 (quotation omitted).

In separate decisions postdating Robert Glover , we remanded three of defendants’ § 2255 motions for a similar hearing–those of Randy Glover, Roy Glover, and Youngpeter. Based on this court’s remands, the district court held an evidentiary hearing on February 23, 1999. These defendants were present at the hearing and represented by counsel (Roy Glover has subsequently become pro se). The government produced three witnesses: (1) Earl Beaver, an agent for the Oklahoma Bureau of Narcotics; (2) John C. Salley, a special agent for the Drug Enforcement Agency (DEA); and (3) Dr. William Kent Glanville, a senior

1 At the time of defendants’ sentencings, the sentencing guidelines in effect differentiated between l-methamphetamine and d-methamphetamine, treating the latter more harshly. See United States v. Robert Glover , 97 F.3d 1345, 1347 (10th Cir. 1996). The guidelines no longer distinguish between the two. See id at 1347 n.2.

forensic chemist employed by the DEA in Texas. The evidence at the hearing was the same as that presented by the government in earlier similar hearings. See United States v. Youngpeter , No. 97-5142, 1998 WL 171838, at **5 (10th Cir. April 13, 1998) (discussing Dr. Glanville’s testimony in an earlier hearing).

As an initial matter, the district court denied defendants’ outstanding motions to exclude forensic evidence and the hearing proceeded. The first witness, Mr. Beaver, who helped execute a search warrant in April 1989, testified generally about defendants’ clandestine methamphetamine laboratory. See R., Vol. VIII at 6-35. Next, Mr. Salley, also present when the search warrant was executed, testified that he collected chemical samples at the scene and sent them to the DEA’s laboratory in Dallas for analysis. See id. at 38-39; 43-44. The government’s last witness, Dr. Glanville, testified that he tested the substances sent by Mr. Salley by performing a mycrocrystal test, and found them to be d, l-methamphetamine. See id. at 52-53. He also testified that if a drug lab manufactures methamphetamine using the controlled substance phenyl-2-propanone–the “p2p” method–the result is production of both d- and l-methamphetamine, i.e., d, l-methamphetamine. See id. at 49-51, 65. According to Dr. Glanville, the substances recovered at the clandestine laboratory contained p2p, see id. at 55, and it is apparent from his testimony defendants were using the p2p method of methamphetamine production. See id. at 49-56. For sentencing

purposes, d, l-methamphetamine is treated the same as d-methamphetamine. See United States v. Decker , 55 F.3d 1509, 1512-13 (10th Cir. 1995).

At the close of the hearing, the court questioned the government vigorously why for eight years it had denied the existence of drug samples and chemical analyses. The government was not able to explain its lapse. The district court then ruled from the bench as follows:

[I]t’s clear that the evidence establishes beyond a reasonable doubt that this was a dl drug.

It is exceedingly unfortunate that these tests were not made available, although I can only say from the little experience I’ve had in the law, that it was to [defendants’] benefit in the long run, because it made the prosecution more difficult. I can’t imagine the government not having brought this forward had they known about it.

I was very interested as to why this occurred, but apparently nobody knows. It must be one of those mysteries.

But the Court must look to the evidence that’s presented at this hearing. That’s the purpose of the hearing. The sole and only evidence that’s been presented is that the product from the residues that were found was methamphetamine, and it was a dl-Methamphetamine. We’re here, actually, because the sentencing commission at sometime in its wisdom came out with a differential in the sentencing guidelines that dealt with d and l-Methamphetamine.

That’s all been abolished now, because they have determined that it was kind of foolish from the first that they did that. But that doesn’t change anything. These gentleman are entitled to those guidelines to be applied as they were at the time of the sentencing.

But the evidence is conclusive. It’s the only evidence that’s been brought before the Court that the methamphetamine that was under consideration of the prosecution and the conviction, and what the Court should have considered at the sentencing was a dl, a d guideline, sentencing guideline, and that’s what the Court did.

Free access — add to your briefcase to read the full text and ask questions with AI

Glover v. United States, (10th Cir. 2000).

Glover v. United States (Glover v. United States) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anders v. California
386 U.S. 738 (Supreme Court, 1967)
Ashe v. Swenson
397 U.S. 436 (Supreme Court, 1970)
Slack v. McDaniel
529 U.S. 473 (Supreme Court, 2000)
United States v. Youngpeter
83 F.3d 434 (Tenth Circuit, 1996)
United States v. Glover
97 F.3d 1345 (Tenth Circuit, 1996)
United States v. Lopez
100 F.3d 113 (Tenth Circuit, 1996)
United States v. Youngpeter
145 F.3d 1347 (Tenth Circuit, 1998)
Miller v. Marr
141 F.3d 976 (Tenth Circuit, 1998)
Rascon v. U S West Communications, Inc.
143 F.3d 1324 (Tenth Circuit, 1998)
Dodge v. Cotter Corporation
203 F.3d 1190 (Tenth Circuit, 2000)
In Re David L. Smith
10 F.3d 723 (Tenth Circuit, 1993)
United States v. Douglas Miles Decker
55 F.3d 1509 (Tenth Circuit, 1995)
United States v. Christopher Simmonds
111 F.3d 737 (Tenth Circuit, 1997)
United States v. Murleen Kay Kunzman
125 F.3d 1363 (Tenth Circuit, 1997)
United States v. Randy Glover
156 F.3d 1244 (Tenth Circuit, 1998)
The Evergreens v. Nunan
141 F.2d 927 (Second Circuit, 1944)